|
|
|
|
|
|
|
|
|
|
Previous: NOVEN PHARMACEUTICALS INC, 10-Q, EX-10.2, 2000-11-13 |
Next: JONES FINANCIAL COMPANIES LP LLP, 10-Q, 2000-11-13 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY UNAUDITED FINANCIAL INFORMATION EXTRACTED FROM
NOVEEN PHARMACEUTICALS, INC. FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2000
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 20,800
<SECURITIES> 0
<RECEIVABLES> 6,898
<ALLOWANCES> 141
<INVENTORY> 5,338
<CURRENT-ASSETS> 35,565
<PP&E> 22,349
<DEPRECIATION> 6,947
<TOTAL-ASSETS> 70,539
<CURRENT-LIABILITIES> 11,018
<BONDS> 0
0
0
<COMMON> 2
<OTHER-SE> 70,468
<TOTAL-LIABILITY-AND-EQUITY> 70,539
<SALES> 30,807
<TOTAL-REVENUES> 31,247
<CGS> 13,951
<TOTAL-COSTS> 29,007
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 773
<INCOME-PRETAX> 9,396
<INCOME-TAX> 470
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 8,926
<EPS-BASIC> .41
<EPS-DILUTED> .39
</TABLE>
|
|